MEST and ovarian cancer: In conclusion, the current study provides evidence indicating that NEAT1 can potentially promote the growth, migration, and invasion of ovarian cancer cells in vitro as well as tumor growth in vivo by competitively binding to let-7 g, promoting MEST expression and inhibiting ATGL expression (Fig. 7).